ArticleCureus2025
Low-Grade Glioma in the Differential Diagnosis of Limbic Encephalitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Postoperative Anti-NMDA Receptor Encephalitis Following Resection of an Insular Astrocytoma: A Case Report.Brain tumor research and treatment · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLimbic encephalitis (LE) is an inflammatory syndrome affecting the limbic system, often presenting with seizures, memory impairment, and behavioral disturbances. While autoimmune and infectious causes are common, gliomas can mimic this condition, leading to diagnostic challenges.
methodsA retrospective review of glioma cases initially diagnosed as LE was conducted at two centers in Mexico (The American British Cowdray and National Institute of Neurology and Neurosurgery) from 2010 to 2022. Inclusion criteria included acute clinical presentation, magnetic resonance imaging (MRI) T2 hyperintensities in the limbic system, lumbar puncture, paraneoplastic panel, cerebrospinal fluid (CSF) viral studies, and histopathological confirmation. Patients with infectious, autoimmune, or other identified etiologies were excluded.
resultsNine patients (mean age 45.2 years; six males, three females) met the criteria. Initial presentations included seizures (5/9), encephalopathy (5/9), fever (1/9), and psychotic symptoms (2/9). MRI revealed limbic system hyperintensities with minimal contrast enhancement. Spectroscopy and perfusion MRI findings suggested low-grade gliomas (LGGs). Histopathology confirmed astrocytoma (5/9), oligoastrocytoma (3/9), and oligodendroglioma (1/9). All patients received steroids, and some received additional therapies (plasma exchange (PLEX), acyclovir, immunoglobulin).
conclusionsGliomas can present as LE, leading to potential misdiagnosis. Advanced imaging and histopathological confirmation are essential for accurate differentiation, ensuring appropriate treatment and improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.